Regenerative medicine is an emerging field of medicine focused on restoring or replacing damaged or diseased cells, tissues, and organs. It is an interdisciplinary field that combines engineering, biology, and medicine to create new treatments for various health conditions. Regenerative medicine has the potential to improve the quality of life of patients suffering from a wide range of diseases and conditions, including cancer, diabetes, heart disease, and stroke. The goal of regenerative medici...

The report "Regenerative Medicine Market by Product (Cell Therapy (Autologous, Allogenic), Gene Therapy, Tissue Engineering (Scaffold, Hydrogels), Application (Musculoskeletal, Oncology, Cardiovascular, Ophthalmology, Wound Care), Region - Global Forecast to 2027", is projected to reach USD 40.6 billion by 2027 from USD 12.2 billion in 2022, at a CAGR of 27.2% during the forecast period. The major factors driving the growth of the regenerative medicine market are the availability of funding and ...

The Regenerative Medicine Market is expected to reach $17.9 billion by 2025, at a CAGR of 15.9%. Market growth is driven by rising investments in regenerative medicine research, and the growing pipeline of regenerative medicine products, and the increase in prevalence of chronic diseases, genetic disorders, and cancer. Key Players: 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporatio...